Regulations.gov document
Psychopharmacologic Drugs Advisory Committee; Cancellation
Notice · FDA-2016-N-0001 · posted Jan 19, 2017
Key facts
| Document ID | FDA-2016-N-0001-0132 |
|---|---|
| Title | Psychopharmacologic Drugs Advisory Committee; Cancellation |
| Document type | Notice |
| Subtype | Meeting |
| Agency | FDA |
| Docket | FDA-2016-N-0001 |
| Posted | Jan 19, 2017 |
| Federal Register citation | 82 FR 6564 |
| FR document number | 2017-01170 |
| Comment period opens | Jan 19, 2017 |
| Effective date | Jan 19, 2017 |
At a glance
- 1–9 Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: